Vantis Institute Announces First Appointment To Advisory Board

From the Vantis Institute:

March 3 2020

NEWPORT BEACH, CA. -- Vantis Institute, LLC. -- Vantis Institute announces the appointment of its first member to its Advisory Board, Dr. Carson Bruns, a leading and acclaimed pioneer in the study of molecular nanotechnology. Dr. Bruns is an Assistant Professor of Mechanical Engineering with the ATLAS Institute at the University of Colorado, Boulder where he directs the Emerging Nanomaterials Laboratory. He received a Ph.D. in Organic Chemistry from Northwestern University under the guidance of Nobel Laureate J. Fraser Stoddart and was a Miller Research Fellow at the University of California, Berkeley. His research uses molecular nanotechnology to develop new materials with applications in areas such as biomedicine, energy transduction, and human-computer interfaces. Dr. Bruns has co-authored over 40 peer-reviewed scientific publications.

Vantis believes Dr. Bruns appointment is opportune as the company continues to develop innovative technology within the medical aesthetics industry. “Dr. Bruns's work has been extraordinary, he has invented a nanotechnology pigment that is deposited into the skin and changes color when exposed to signals such as ultraviolet light or heat,” states Vantis Clinical Director, Jessica Oslo. Ms. Oslo continued, “We appreciate the accomplishments by Dr. Bruns as both a researcher and Director of the only laboratory focused on emergent nanotechnology with biomedical pigment applications.”

Vantis Institute in Newport Beach developed an innovative solution for people suffering from hair loss. In the US, hair loss is estimated to affect over 35 million men and over 21 million women. Americans currently spend over $11.1 billion annually on hair loss treatments. Vantis Institute disrupted the industry with the development of a non-surgical hair-loss solution, called Vantis Follicle Replication (VFRTM). Their patent-pending technology covers the combination of aesthetic pigments with therapeutic agents.

Dr. Bruns stated, “I look forward to working with the Vantis team to leverage my experience with innovative science and research. Vantis shares my passion to optimize the human experience and I look forward to exploring new opportunities together in medical aesthetics.”

This press release was produced by the Vantis Institute. The views expressed here are the author’s own.